Last reviewed · How we verify
NCT07514585
Feasibility Study on the Application of Bionic Healing Abutments in Implant Impressions
trial in Dentition Defect in 8 participants. Enrolling by invitation.
31 July 2027
Quick facts
| Lead sponsor | Fujian Medical University |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 8 |
| Start date | 1 December 2024 |
| Primary completion | 31 July 2027 |
| Estimated completion | 31 July 2027 |
| Sites | 1 location across China |
Conditions studied
- Dentition Defect — all drugs for Dentition Defect →
- Healing Abutment — all drugs for Healing Abutment →
Sponsor
Fujian Medical University
Who can join
Adults 18 to 65, any sex, with Dentition Defect or Healing Abutment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The bionic healing abutment of the group's previous research results has both soft tissue shaping and impression taking functions, realizing the advantages of no need to dismantle the impression, simplifying clinical operation, maintaining soft tissue closure and reducing patient discomfort, responding to the requirements of the new quality productivity. On this basis, this study is intended to explore the accuracy of implant restorative impressions with bionic healing abutment and transfer bar in the impression of membrane material, and with bionic healing abutment and scanning bar in the digital impression in the case of different parts of the missing teeth and different numbers of missing teeth, so as to provide a basis for the application of bionic healing abutment in implant restorative impressions and guidance on the use of the clinic.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07514585
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Fujian Medical University trials
Trials by the same sponsor.
- NCT07314203 — Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastr · Phase 3 · not yet recruiting
- NCT07491263 — Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Le · Phase 1 · not yet recruiting
- NCT07275034 — A Virtual Reality-Based Horticultural Planting Program for Elderly With Subthreshold Depression · NA · not yet recruiting
- NCT07383909 — Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery · NA · recruiting
- NCT07419932 — Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07514585 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fujian Medical University
- Last refreshed: 7 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07514585.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing